CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Ordinary Shares	Ordinary Shares Performance-Based Restricted Stock Units (PRSUs)	Non-voting Euro Deferred	Capital Redemption Reserve	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance (in shares) at Dec. 31, 2023		62,255		4,000
Beginning balance at Dec. 31, 2023	$ 3,736,997	$ 6		$ 55	$ 473	$ 3,699,954	$ (842,147)	$ 878,656
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of ordinary shares in conjunction with exercise of share options (in shares)		7
Issuance of ordinary shares in conjunction with exercise of share options	494					494
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)		686	80
Shares withheld for payment of employees' withholding tax liability	(49,296)					(49,296)
Share-based compensation	63,131					63,131
Other comprehensive income (loss)	(40,247)						(40,247)
Net (loss) income	(14,618)							(14,618)
Ending balance (in shares) at Mar. 31, 2024		63,028		4,000
Ending balance at Mar. 31, 2024	3,696,461	$ 6		$ 55	473	3,714,283	(882,394)	864,038
Beginning balance (in shares) at Dec. 31, 2023		62,255		4,000
Beginning balance at Dec. 31, 2023	3,736,997	$ 6		$ 55	473	3,699,954	(842,147)	878,656
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Other comprehensive income (loss)	238,750
Net (loss) income	369,005
Ending balance (in shares) at Sep. 30, 2024		60,443		4,000
Ending balance at Sep. 30, 2024	4,171,067	$ 6		$ 55	473	3,837,698	(603,397)	936,232
Beginning balance (in shares) at Mar. 31, 2024		63,028		4,000
Beginning balance at Mar. 31, 2024	3,696,461	$ 6		$ 55	473	3,714,283	(882,394)	864,038
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of ordinary shares in conjunction with exercise of share options (in shares)		4
Issuance of ordinary shares in conjunction with exercise of share options	54					54
Issuance of ordinary shares under employee stock purchase plan (in shares)		122
Issuance of ordinary shares under employee stock purchase plan	10,886					10,886
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)		49
Shares withheld for payment of employees' withholding tax liability	(2,847)					(2,847)
Share-based compensation	56,738					56,738
Shares repurchased (in shares)		(1,458)
Shares repurchased	(161,428)							(161,428)
Other comprehensive income (loss)	(5,833)						(5,833)
Net (loss) income	168,568							168,568
Ending balance (in shares) at Jun. 30, 2024		61,745		4,000
Ending balance at Jun. 30, 2024	3,762,599	$ 6		$ 55	473	3,779,114	(888,227)	871,178
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of ordinary shares in conjunction with exercise of share options (in shares)		1
Issuance of ordinary shares in conjunction with exercise of share options	17					17
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)		69
Shares withheld for payment of employees' withholding tax liability	(1,605)					(1,605)
Share-based compensation	60,172					60,172
Shares repurchased (in shares)		(1,372)
Shares repurchased	(150,001)							(150,001)
Other comprehensive income (loss)	284,830						284,830
Net (loss) income	215,055							215,055
Ending balance (in shares) at Sep. 30, 2024		60,443		4,000
Ending balance at Sep. 30, 2024	4,171,067	$ 6		$ 55	473	3,837,698	(603,397)	936,232
Beginning balance (in shares) at Dec. 31, 2024		60,631		4,000
Beginning balance at Dec. 31, 2024	4,093,756	$ 6		$ 55	473	3,913,542	(947,667)	1,127,347
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of ordinary shares in conjunction with exercise of share options (in shares)		93
Issuance of ordinary shares in conjunction with exercise of share options	11,447					11,447
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)		811	88
Shares withheld for payment of employees' withholding tax liability	(67,163)					(67,163)
Share-based compensation	67,335					67,335
Other comprehensive income (loss)	162,057						162,057
Net (loss) income	(92,541)							(92,541)
Ending balance (in shares) at Mar. 31, 2025		61,623		4,000
Ending balance at Mar. 31, 2025	4,174,891	$ 6		$ 55	473	3,925,161	(785,610)	1,034,806
Beginning balance (in shares) at Dec. 31, 2024		60,631		4,000
Beginning balance at Dec. 31, 2024	4,093,756	$ 6		$ 55	473	3,913,542	(947,667)	1,127,347
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Other comprehensive income (loss)	377,769
Net (loss) income	(559,599)
Ending balance (in shares) at Sep. 30, 2025		60,740		4,000
Ending balance at Sep. 30, 2025	3,959,030	$ 6		$ 55	473	4,085,669	(569,898)	442,725
Beginning balance (in shares) at Mar. 31, 2025		61,623		4,000
Beginning balance at Mar. 31, 2025	4,174,891	$ 6		$ 55	473	3,925,161	(785,610)	1,034,806
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of ordinary shares in conjunction with exercise of share options (in shares)		1
Issuance of ordinary shares in conjunction with exercise of share options	0					0
Issuance of ordinary shares under employee stock purchase plan (in shares)		117
Issuance of ordinary shares under employee stock purchase plan	10,497					10,497
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)		41
Shares withheld for payment of employees' withholding tax liability	(2,249)					(2,249)
Share-based compensation	66,871					66,871
Shares repurchased (in shares)		(1,142)
Shares repurchased	(125,023)							(125,023)
Other comprehensive income (loss)	299,842						299,842
Net (loss) income	(718,470)							(718,470)
Ending balance (in shares) at Jun. 30, 2025		60,640		4,000
Ending balance at Jun. 30, 2025	3,706,359	$ 6		$ 55	473	4,000,280	(485,768)	191,313
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of ordinary shares in conjunction with exercise of share options (in shares)		7
Issuance of ordinary shares in conjunction with exercise of share options	733					733
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)		82	11
Shares withheld for payment of employees' withholding tax liability	(3,812)					(3,812)
Share-based compensation	88,468					88,468
Other comprehensive income (loss)	(84,130)						(84,130)
Net (loss) income	251,412							251,412
Ending balance (in shares) at Sep. 30, 2025		60,740		4,000
Ending balance at Sep. 30, 2025	$ 3,959,030	$ 6		$ 55	$ 473	$ 4,085,669	$ (569,898)	$ 442,725